Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 9/2014

01-09-2014 | Letter to the Editor

Idiopathic retroperitoneal fibrosis: IgG4 infiltration in a cohort of Spanish patients

Authors: Andreu Fernández-Codina, Fernando Martínez-Valle, Jesús Castro-Marrero, Inés De Torres, Miquel Vilardell-Tarrés, José Ordi-Ros

Published in: Rheumatology International | Issue 9/2014

Login to get access

Excerpt

Sir, …
Literature
1.
Kermani TA, Crowson CS, Achenbach SJ, Luthra HS (2011) Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 86:297–303PubMedCentralPubMedCrossRef
2.
Yamashita K, Haga H, Mikami Y, Kanematsu A, Nakashima Y, Kotani H et al (2008) Degree of IgG4+ plasma cell infiltration in retroperitoneal fibrosis with or without multifocal fibrosclerosis. Histopathology 52:404–409PubMedCrossRef
3.
Fernández-Codina A, Martínez-Valle F, Castro-Marrero J, Detorres I, Vilardell-Tarrés M, Ordi-Ros J (2013) Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases. Clin Rheumatol 32:889–893PubMedCrossRef
4.
Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192PubMedCrossRef
5.
Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T et al (2009) Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 33:1833–1839PubMedCrossRef
6.
Khosroshahi A, Carruthers MN, Stone JH, Shinagare S, Sainani N, Hasserjian RP et al (2013) Rethinking Ormond’s disease: “idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 92:82–91CrossRef
7.
Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T (2010) Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreatology 10:664–672PubMedCrossRef
8.
Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R et al (2011) Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 378:338–346PubMedCrossRef
Metadata
Title
Idiopathic retroperitoneal fibrosis: IgG4 infiltration in a cohort of Spanish patients
Authors
Andreu Fernández-Codina
Fernando Martínez-Valle
Jesús Castro-Marrero
Inés De Torres
Miquel Vilardell-Tarrés
José Ordi-Ros
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 9/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2936-4

Other articles of this Issue 9/2014

Rheumatology International 9/2014 Go to the issue

Original Article

Comparison of the therapeutic effects of intramuscular subscapularis and scapulothoracic bursa injections in patients with scapular pain: a randomized controlled trial

Original Article

The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch–Schonlein purpura

Reply

Response to: Mean platelet volume and neutrophil-to-lymphocyte ratio in patients with Henoch–Schonlein purpura

Original Article

Culture-sensitive adaptation and validation of the Community-Oriented Program for the Control of Rheumatic Diseases methodology for rheumatic disease in Latin American indigenous populations

Letter to the Editor

Mean platelet volume and neutrophil-to-lymphocyte ratio in patients with Henoch-Schonlein purpura

Original Article

Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits